NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
Clinical Trials
89 trialsNCT04377932 2026-01-21
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Baylor College of Medicine
Phase 1 Active not recruiting
NCT03611309 2026-01-08
PERIOP-PC
Stanford University
Phase NA Completed
NCT00183885 2025-10-30
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
University of Southern California
Phase 2 Completed
NCT02881554 2025-10-29
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
University of Washington
Phase NA Terminated
NCT00976898 2025-09-15
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Massachusetts General Hospital
Phase NA Completed
NCT01356628 2025-07-28
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
Thomas Jefferson University
Phase 2 Completed
NCT02185768 2025-07-04
IDASPHERE II
Federation Francophone de Cancerologie Digestive
Phase 2 Completed
NCT01754987 2025-05-04
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Thomas Jefferson University
Phase 1/2 Completed
NCT01205828 2025-02-12
ABT-888 and Temozolomide for Liver Cancer
Georgetown University
Phase 2 Terminated
NCT02349412 2025-02-07
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04272619 2025-01-08
Liver Cancer Community Education
Fox Chase Cancer Center
Phase NA Completed
NCT05717400 2024-12-31
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT00410956 2024-12-10
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02722616 2024-01-18
Ultrasound Monitoring of Abdominal Soft Tissue
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT01401907 2023-10-19
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Massachusetts General Hospital
Phase NA Completed
NCT00539643 2023-08-18
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00788125 2023-07-14
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Phase 1/2 Terminated
NCT02424955 2023-07-11
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
Stanford University
Phase NA Completed
NCT00813293 2023-06-13
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT00587067 2023-04-04
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04172714 2022-12-06
Low-dose Y90 Treatment Planning for HCC
Emory University
Phase NA Completed
NCT00956930 2022-11-21
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
Northwestern University
Phase 2 Completed
NCT01180959 2022-11-07
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02489422 2022-10-14
PRO-YOU
Wake Forest University Health Sciences
Phase NA Completed
NCT02575339 2022-07-26
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Big Ten Cancer Research Consortium
Phase 1/2 Terminated
NCT00746590 2022-07-21
Study of Anti-tumour Effects and Safety of Prolarixâ„¢ in Hepatocellular Carcinoma
BTG International Inc.
Phase 2 Terminated
NCT01666145 2022-04-22
Advanced Image Guidance Utilized in Liver Surgery
Wake Forest University Health Sciences
Phase NA Completed
NCT00867321 2022-04-19
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Alliance for Clinical Trials in Oncology
Phase 1/2 Completed
NCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT03926039 2021-10-29
Sharing Decision-making Program for HCC Patients Treatment Decisions
National Taipei University of Nursing and Health Sciences
Phase NA Completed
NCT03644173 2021-10-15
Personal Resilience Empowerment Program Study
Hackensack Meridian Health
Phase NA Completed
NCT01098422 2021-08-24
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
University of California, San Diego
Phase NA Terminated
NCT00335829 2021-08-13
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Yale University
Phase 2 Completed
NCT02291133 2021-07-23
ECT-HCC
University Medical Centre Ljubljana
Phase 1/2 Completed
NCT01032850 2021-06-02
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT00543777 2021-04-13
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02548910 2021-03-18
PRICE
Ottawa Hospital Research Institute
Phase NA Completed
NCT03338062 2021-02-26
A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy
Indiana University
Phase NA Completed
NCT01264705 2020-11-12
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT02966223 2020-09-25
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
Indiana University
Phase NA Terminated
NCT00049322 2020-09-01
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT02461966 2020-08-14
Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta
Tanta University
Phase NA Completed
NCT02753881 2020-08-03
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
Yale University
Phase 1 Completed
NCT01099631 2020-07-20
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT01871545 2020-07-09
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT01775501 2020-04-22
Sorafenib + mFOLFOX for Hepatocellular Carcinoma
Massachusetts General Hospital
Phase 2 Completed
NCT01877187 2020-04-15
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Yale University
Phase 2 Completed
NCT02018107 2020-03-26
PET/CT-Assessment of Liver Tumor Ablation
Dana-Farber Cancer Institute
Phase NA Completed